Increased intake of vitamin K2 may reduce the risk of prostate cancer by 35 percent, according to the results of European Prospective Investigation into Cancer and Nutrition (EPIC).
The potential benefits of K2 were most pronounced for advanced prostate cancer. Vitamin K1 intake did not offer any prostate benefits.
The findings were based on data from more than 11,000 men taking part in the EPIC Heidelberg cohort. It adds to a small but ever-growing body of science supporting the potential health benefits of vitamin K for bone, blood, skin, and now prostate health.